Further more, lower mortality rates were reported in patients who responded to methotrexate and lower work disability rates were noted in patients who responded to anti-rheumatic drugs [4] .
Although improvements were seen in clinical outcomes, it was a long time before studies showed changes in the rates of TJR. Only in the last 10 years have studies from Western countries and Japan suggested that rates of TJR and other RA-related surgeries have been stable or decreased in patients with RA [5] [6] [7] [8] [9] [10] [11] [12] [13] , as now reported also by Hekmat and colleagues [1] . Declining trends of TJR surgeries in patients with RA contrasts with a remarkable phenomenon of the increase in overall rates of TJR surgery of the knee or hip documented in the general population of many countries having doubled since 1990, and increased threefold since the early 1980s [5, 14, 15] .
Hekmat and colleagues [1] identifi ed prevalent cases with RA in 1997 and incident cases from 1997 to 2007 in a community-based register in Malmö, Sweden, and linked them to the Swedish hip and knee arthroplasty registers. Th e incidence of a primary TJR of the hip or knee in 1998-2001 (before tumor necrosis factor inhibitors were available for the treatment of RA) was compared with that in 2002-2006/07 (after these inhibitors became available). A decline was seen in the incidence of the primary hip TJR from 12.6 to 6.6 per 1,000 person-years, whereas a slight trend toward an increase of primary TJR of the knee was observed.
What does this study teach us? First, this study provides further evidence of improving outcomes of RA. TJR of the hip or knee is a severe long-term outcome for patients with RA and accounts for a substantial component of the costs of this disease [16] . Overall rates of TJR surgery of the hip or knee in general population have been documented to have been doubled since 1990 and increased threefold since the early 1980s in many countries. Th ese fi ndings indicate an increased need, associated with aging of the population, for TJR surgery in the population and apparently availability of greater resources to perform these procedures. 
